camptothecin has been researched along with cytochalasin b in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Cotter, TG; Glynn, JM; Green, DR; Lennon, SV | 1 |
| Cheng, J; Hemstreet, GP; Jin, YS; Rao, JY; Tai, J; Zheng, Q | 1 |
3 other study(ies) available for camptothecin and cytochalasin b
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis.
Topics: Actin Cytoskeleton; Aphidicolin; Camptothecin; Cell Death; Cell Line; Cell Survival; Cytochalasin B; Humans; Ionomycin; Kinetics; Leukemia; Tetradecanoylphorbol Acetate; Ultraviolet Rays | 1992 |
Alterations of the actin polymerization status as an apoptotic morphological effector in HL-60 cells.
Topics: Actins; Antineoplastic Agents; Apoptosis; Biopolymers; Camptothecin; Cell Survival; Cytochalasin B; Cytochalasins; Deoxyribonuclease I; Depsipeptides; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; HL-60 Cells; Humans; In Situ Nick-End Labeling; Microscopy, Fluorescence; Peptides, Cyclic; Time Factors | 1999 |